NRT + Quit Practice Strategies for Smoking Cessation
(ON-DEQ Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores new methods to help people quit smoking by testing various counseling and nicotine replacement therapy (NRT) approaches. It compares two counseling types: Practice Quitting, which encourages short, pressure-free attempts to stop smoking, and Motivational Interviewing, which enhances motivation to quit. Participants will receive either a supply of nicotine lozenges and patches or none at all. Smokers who have been smoking at least five cigarettes a day, are not planning to quit within the next month, and want to learn about reducing smoking or quitting in the next six months might be a good fit for this study. As a Phase 1, Phase 2 trial, this research aims to understand how the treatment works in people and measure its effectiveness in an initial, smaller group, offering participants a chance to contribute to groundbreaking smoking cessation strategies.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, if you have any FDA contraindications for nicotine replacement therapy (NRT), such as recent cardiovascular issues, you may be excluded from the trial.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that nicotine replacement therapy (NRT), such as patches and lozenges, is generally safe for adults who want to quit smoking. Many people use NRT to manage cravings and withdrawal symptoms. While some side effects may occur, they are usually mild, such as headaches, nausea, or dizziness. The US Food and Drug Administration (FDA) provides guidelines to ensure the safe use of these therapies.
Motivational Interviewing (MI) counseling has proven effective in helping people quit smoking by increasing their motivation and commitment. Studies confirm that MI is effective and generally well-received by those trying to quit.
Practice Quitting (PQ) counseling is a newer method with limited safety data. However, it involves short-term attempts to stop smoking, which is low-risk. While specific safety data is limited, the method itself is non-invasive and considered safe.
Overall, these treatments aim to help people stop smoking and have shown promising safety profiles in previous studies.12345Why are researchers excited about this trial's treatments?
Researchers are excited about this trial because it explores different counseling strategies combined with nicotine replacement therapy (NRT) to help people quit smoking. The trial is unique as it compares the effectiveness of Motivational Interviewing (MI) and Practice Quitting (PQ) counseling, two behavioral techniques designed to boost motivation and prepare individuals for a successful quit attempt. Unlike standard methods that might rely solely on NRT or generic advice, this trial aims to uncover how tailored behavioral support can enhance quitting success. By understanding which combination works best, researchers hope to offer more personalized and effective quitting strategies for smokers.
What evidence suggests that this trial's treatments could be effective for smoking cessation?
This trial will evaluate different strategies for smoking cessation, including Nicotine Replacement Therapy (NRT) and behavioral counseling methods. Studies have shown that NRT, which some participants will receive, can more than double the chances of successfully quitting smoking by providing a small amount of nicotine to reduce cravings and withdrawal symptoms. Other participants will receive Motivational Interviewing (MI) counseling, which research suggests can help people quit smoking by boosting motivation and readiness to quit, although its effects are usually modest. Additionally, some participants will experience Practice Quitting (PQ) counseling, which, while less researched, provides structured support known to increase the chances of quitting. Overall, each of these methods has shown promise in helping people quit smoking, and they work in different ways to support efforts to quit.36789
Who Is on the Research Team?
Amanda R Mathew, PhD
Principal Investigator
Rush University Medical Center
Are You a Good Fit for This Trial?
This trial is for English-speaking adults in the continental U.S. who smoke daily (5+ cigarettes) and aren't planning to quit within 30 days but are considering quitting or reducing smoking within 6 months. They must have a smartphone for study procedures. It's not for those who vape daily, are pregnant/breastfeeding, or have had recent heart attacks or strokes.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive PQ counseling vs. Motivational Interviewing and NRT sampling (four-week supply of nicotine lozenges and patches) vs. none
Follow-up
Participants are monitored for quit attempts and abstinence status at 1, 3, and 6 months
What Are the Treatments Tested in This Trial?
Interventions
- Motivational Interviewing (MI) Counseling
- Nicotine Replacement Therapy (NRT) Sampling
- Practice Quitting (PQ) Counseling
Motivational Interviewing (MI) Counseling is already approved in United States, Canada, European Union for the following indications:
- Smoking cessation
- Substance abuse treatment
- Smoking cessation
- Addiction treatment
- Smoking cessation
- Behavioral therapy
Find a Clinic Near You
Who Is Running the Clinical Trial?
Rush University Medical Center
Lead Sponsor
Medical University of South Carolina
Collaborator